Elan Drug Technologies, a business unit of Elan Corporation, plc has received the top award for Technology Innovation at the recent Drug Delivery Partnership (DDP) meeting for its NanoCrystal technology. NanoCrystal technology was voted the most successful drug delivery technology innovation. Designed to overcome issues associated with poor water solubility, in the ten years since its first filing with the FDA, products using this technology are now marketed in over 100 territories worldwide and have gone on to achieve product in-market sales of $7.5B+ for its clients.
Shane Cooke, the Executive Vice President and Head of Elan Drug Technologies, said, “This technology continues to be a major commercial success for our licensees. We strive to continue developing technologies and products that are innovative, unique and market relevant so as to provide true patient benefit to our clients.”
This news was featured in Drug Discovery & Development magazine: Vol. 13, No. 3, April 2010, p. 36.
Filed Under: Drug Discovery